CLEXIO BIOSCIENCES

clexio-biosciences-logo

Clexio Biosciences is a clinical-stage pharmaceutical company that integrates drugs and new technologies to deliver clinical benefits to patients. The company was founded in 2018 and is based in Jerusalem, Israel.

#SimilarOrganizations #People #Website #More

CLEXIO BIOSCIENCES

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2018-03-01

Address:
Jerusalem, Yerushalayim, Israel

Country:
Israel

Website Url:
http://www.clexio.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager WordPress Domain Not Resolving Sitelinks Search Box Euro Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins


Similar Organizations

alphamab-oncology-logo

Alphamab Oncology

Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.

epivax-logo

EpiVax

EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.

holy-stone-healthcare-logo

Holy Stone Healthcare

Holy Stone Healthcare is developing lifesaving therapeutics and targeted delivery technologies to improve the quality of life .

nivalis-therapeutics-logo

Nivalis Therapeutics

Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.

Current Employees Featured

menashe-levy_image

Menashe Levy
Menashe Levy Co-founder & CTO @ Clexio Biosciences
Co-founder & CTO
2018-04-01

elisabeth-kogan_image

Elisabeth Kogan
Elisabeth Kogan CEO & Co-founder @ Clexio Biosciences
CEO & Co-founder
2018-04-01

Founder


elisabeth-kogan_image

Elisabeth Kogan

menashe-levy_image

Menashe Levy

Official Site Inspections

http://www.clexio.com

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Clexio Biosciences"

About Us - Clexio

About Clexio Clexio is a clinical-stage company designing novel drugs based on validated Mechanisms of Action in NeuroPsychiatry. We are developing innovative therapies to address โ€ฆSee details»

Clexio Biosciences - Crunchbase Company Profile

Organization. Clexio Biosciences . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Clexio Biosciences โ€ฆSee details»

Clexio Biosciences - The Org

Clexio Biosciences is a CNS-first clinical-stage pharmaceutical company. Our therapies are designed to address patientsโ€™ unmet needs through scientifically based integration of drugs โ€ฆSee details»

Clexio Biosciences - Israeli Startup | Startup Nation Finder

Oct 23, 2024 Note that you need to have an email in this organization in order to claim the profile. Name* Work Email* (please provide your email in the organization) Position* Notes. โ€ฆSee details»

Clexio Biosciences - Overview, News & Similar companies

Who is Clexio Biosciences. Clexio Biosciences is a clinical-stage pharmaceutical company dedicated to the development of novel treatments designed to deliver clinical benefit s to โ€ฆSee details»

Clexio Biosciences Ltd.

Clexio Biosciences is a CNS-first clinical stage company. We are dedicated to developing novel therapies for patients suffering from neurological and psychiatric conditions. Learn More โ€ฆSee details»

Clexio Biosciences - Leadership Team - The Org

The Leadership Team at Clexio Biosciences, comprising the Chief Medical Officer, CEO and Co-founder, and VP Business Development, spearheads the strategic direction and operational โ€ฆSee details»

Clexio Biosciences Ltd. - Drug pipelines, Patents, Clinical ... - Patsnap

May 7, 2025 Explore Clexio Biosciences Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 3 news, and 2 literature, Disease Domain:Nervous System Diseases, โ€ฆSee details»

Clexio Biosciences - 2025 Company Profile - Tracxn

May 13, 2025 Clexio is a developer of therapeutics for treating pain, depression and other CNS disorders. The products pipeline includes CLE-100 (an oral NMDA modulator) to treat the โ€ฆSee details»

Clexio Biosciences - Psychedelic Finance

Clexio identifies points of convergence between validated mechanisms of action and technology, to generate new patient-centric possibilities. Clexio Biosciences multidisciplinary team brings โ€ฆSee details»

Clexio - VentureRadar

"We are a multi-asset, CNS-first clinical stage pharmaceutical company that grew out of an R&D team at a Big Pharma company. We are dedicated to developing novel drugs and โ€ฆSee details»

Clexio Biosciences Company Profile | Management and ... - Datanyze

Clexio Biosciences is a clinical-stage pharmaceutical company dedicated to the development of novel treatments designed to deliver clinical benefits to patients through sophisticated โ€ฆSee details»

Clexio Biosciences - Contacts, Employees, Board Members

Organization. Clexio Biosciences . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Contacts 12. ... Clexio โ€ฆSee details»

Clexio Biosciences Ltd.

Clexio is a clinical-stage company designing novel drugs based on validated Mechanisms of Action in NeuroPsychiatry. We are developing innovative therapies to address patientsโ€™ unmet โ€ฆSee details»

Pipeline - Clexio

Everything we do is driven by patients and what they have to live with. We innovate and refine solutions that can be integrated in a seamless way into patientsโ€™ lives.See details»

Clexio | VentureRadar

Website: https://www.clexio.com/ We are a multi-asset, CNS-first clinical stage pharmaceutical company that grew out of an R&D team at a Big Pharma company.See details»

Clexio Biosciences - Tech Stack, Apps, Patents & Trademarks

Mar 10, 2025 The intellectual property of Clexio Biosciences includes 64 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. โ€ฆSee details»

Clinical Trials - Clexio

Recently Clexio partnered with the Depression Bipolar Support Alliance (DBSA) to evaluate the readability of the Inform Consent Form (ICF) designed for our Ph2 trial in patients suffering โ€ฆSee details»

News Archive - Clexio

Clexio Biosciences expands its protection of CLE-100 with the issuance of a third US method of use patent and the allowance of an additional three US patents. 10 April 2024 Clexio initiates โ€ฆSee details»

Publications & Presentations - Clexio

A Phase 2 Randomized Controlled Adjunctive Treatment Trial with CLE-100 Esketamine Tablet for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants, โ€ฆSee details»

linkstock.net © 2022. All rights reserved